H.R. 2940 · 118th Congress (2023–2025)
PASTEUR Act
This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $6 billion in appropriations for activities under the bill, and contains other related provisions.
A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.
Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.
HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.
Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.
Show official title
To amend title III of the Public Health Service Act to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 2940’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. IV Ferguson A. Drew (R-GA-3)
- Cosponsors
62 cosponsors
3 original · 59 later
31 R · 31 D
- Rep. Jake LaTurner (R-KS-2)· Original · Apr 27, 2023
- Rep. Mike Levin (D-CA-49)· Original · Apr 27, 2023
- Rep. Scott H. Peters (D-CA-50)· Original · Apr 27, 2023
- Rep. Mark E. Amodei (R-NV-2)· Later · Apr 28, 2023
- Rep. James P. McGovern (D-MA-2)· Later · May 2, 2023
- Rep. Jake Auchincloss (D-MA-4)· Later · May 10, 2023
- Rep. Don Bacon (R-NE-2)· Later · May 10, 2023
- Rep. Yvette D. Clarke (D-NY-9)· Later · May 10, 2023
- Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · May 10, 2023
- Rep. Donald G. Davis (D-NC-1)· Later · May 10, 2023
- Rep. Charles J. "Chuck" Fleischmann (R-TN-3)· Later · May 10, 2023
- Rep. Brian K. Fitzpatrick (R-PA-1)· Later · May 10, 2023
- Del. Eleanor Holmes Norton (D-DC)· Later · May 10, 2023
- Rep. Jimmy Panetta (D-CA-19)· Later · May 10, 2023
- Rep. Deborah K. Ross (D-NC-2)· Later · May 10, 2023
- Rep. Maria Elvira Salazar (R-FL-27)· Later · May 10, 2023
- Rep. Austin Scott (R-GA-8)· Later · May 10, 2023
- Rep. Lisa Blunt Rochester (D-DE)· Later · May 18, 2023
- Rep. Troy A. Carter (D-LA-2)· Later · May 18, 2023
- Rep. Jeff Duncan (R-SC-3)· Later · May 18, 2023
- Rep. Mike Kelly (R-PA-16)· Later · May 18, 2023
- Rep. Ann M. Kuster (D-NH-2)· Later · May 18, 2023
- Rep. Mariannette Miller-Meeks (R-IA-1)· Later · May 18, 2023
- Res. Comm. Jenniffer González-Colón (R-PR)· Later · May 22, 2023
- Rep. Doris O. Matsui (D-CA-7)· Later · May 22, 2023
- Rep. Adrian Smith (R-NE-3)· Later · May 22, 2023
- Rep. Paul Tonko (D-NY-20)· Later · May 22, 2023
- Rep. Diana DeGette (D-CO-1)· Later · Jun 14, 2023
- Rep. David G. Valadao (R-CA-22)· Later · Jun 14, 2023
- Rep. Nanette Diaz Barragán (D-CA-44)· Later · Jun 21, 2023
- Rep. Gregory F. Murphy (R-NC-3)· Later · Jun 21, 2023
- Rep. David Schweikert (R-AZ-1)· Later · Jun 21, 2023
- Rep. Kim Schrier (D-WA-8)· Later · Jun 21, 2023
- Rep. Angie Craig (D-MN-2)· Later · Jun 22, 2023
- Rep. Mark E. Green (R-TN-7)· Later · Jun 22, 2023
- Rep. Mike Carey (R-OH-15)· Later · Jun 27, 2023
- Rep. Bill Johnson (R-OH-6)· Later · Jun 30, 2023
- Rep. Daniel Meuser (R-PA-9)· Later · Jun 30, 2023
- Rep. Mike Quigley (D-IL-5)· Later · Jun 30, 2023
- Rep. Jamie Raskin (D-MD-8)· Later · Jun 30, 2023
- Rep. Larry Bucshon (R-IN-8)· Later · Jul 10, 2023
- Rep. Daniel S. Goldman (D-NY-10)· Later · Jul 10, 2023
- Rep. Terri A. Sewell (D-AL-7)· Later · Jul 12, 2023
- Rep. Jefferson Van Drew (R-NJ-2)· Later · Jul 12, 2023
- Rep. Michael C. Burgess (R-TX-26)· Later · Jul 25, 2023
- Rep. Susie Lee (D-NV-3)· Later · Jul 25, 2023
- Rep. Lucy McBath (D-GA-7)· Later · Sep 14, 2023
- Rep. Jay Obernolte (R-CA-23)· Later · Sep 14, 2023
- Rep. John B. Larson (D-CT-1)· Later · Sep 26, 2023
- Rep. Tracey Mann (R-KS-1)· Later · Sep 26, 2023
- Rep. Juan Ciscomani (R-AZ-6)· Later · Nov 2, 2023
- Rep. Lori Trahan (D-MA-3)· Later · Nov 2, 2023
- Rep. Nicole Malliotakis (R-NY-11)· Later · Nov 29, 2023
- Rep. Joe Neguse (D-CO-2)· Later · Nov 29, 2023
- Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Jan 29, 2024
- Rep. Thomas H. Kean, Jr. (R-NJ-7)· Later · Jan 29, 2024
- Rep. Henry Cuellar (D-TX-28)· Later · Feb 9, 2024
- Rep. Brad R. Wenstrup (R-OH-2)· Later · Feb 9, 2024
- Rep. Ben Cline (R-VA-6)· Later · Mar 6, 2024
- Rep. Jason Crow (D-CO-6)· Later · Mar 6, 2024
- Rep. Frank J. Mrvan (D-IN-1)· Later · May 21, 2024
- Rep. Christopher H. Smith (R-NJ-4)· Later · May 21, 2024
- Policy area
- Health
- Subjects
- Administrative law and regulatory procedures
- Advanced technology and technological innovations
- Advisory bodies
- Appropriations
- Department of Health and Human Services
- Drug therapy
- Executive agency funding and structure
- Government information and archives
7 more
- Government studies and investigations
- Health information and medical records
- Infectious and parasitic diseases
- Medical research
- Prescription drugs
- Public contracts and procurement
- Research and development
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 3 committee actions · Apr 27, 2023 – Dec 17, 2024
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
PASTEUR Act
Display title, Short title · Introduced in House
Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023
Short title · Introduced in House
To amend title III of the Public Health Service Act to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections, and for other purposes.
Official title · Introduced in House